AMN HEALTHCARE SERVICES INC

For the period ended Dec 31, 2023. Filed Feb 22, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 22, 2024

AMN$37.81+0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of December 31, 202 and

(in thousands, except par value)

	December 31,
	2023	2022
ASSETS
Current assets:
Cash and cash equivalents	$32,935	$64,524
Accounts receivable, net of allowances of $32,233 and $31,910 at December 31, 2023 and 2022, respectively	623,488	675,650
Accounts receivable, subcontractor	117,703	268,726
Prepaid expenses	21,889	18,708
Other current assets	45,670	66,037
Total current assets	841,685	1,093,645
Restricted cash, cash equivalents and investments	68,845	61,218
Fixed assets, net of accumulated depreciation of $285,081 and $227,617 at December 31, 2023 and 2022, respectively	191,385	149,276
Other assets	236,796	172,016
Goodwill	1,111,549	935,364
Intangible assets, net of accumulated amortization of $442,052 and $361,327 at December 31, 2023 and 2022, respectively	474,134	476,832
Total assets	$2,924,394	$2,888,351
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$343,847	$476,452
Accrued compensation and benefits	278,536	333,244
Other current liabilities	33,738	48,237
Total current liabilities	656,121	857,933
Revolving credit facility	460,000	—
Notes payable, net of unamortized fees and premium	844,688	843,505
Deferred income taxes, net	23,350	22,713
Other long-term liabilities	108,979	120,566
Total liabilities	2,093,138	1,844,717
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at December 31, 2023 and 2022	—	—
Common stock, $0.01 par value; 200,000 shares authorized; 50,423 issued and 37,810 outstanding at December 31, 2023 and 50,109 issued and 41,879 outstanding at December 31, 2022	504	501
Additional paid-in capital	506,543	501,674
Treasury stock, at cost; 12,613 and 8,230 shares at December 31, 2023 and 2022, respectively	(1,127,043)	(698,598)
Retained earnings	1,451,675	1,240,996
Accumulated other comprehensive loss	(423)	(939)
Total stockholders’ equity	831,256	1,043,634
Total liabilities and stockholders’ equity	$2,924,394	$2,888,351

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.